NYMOX REPORTS NOTICE

California Court Issued A Temporary Restraining Order Enjoining Lanham, Riley, Cutler And Their Nevada Company After Court Hearing In Santa Ana, California, November 2, 2023

Ex-Employees and Agents, and those working in concert with them, are ordered by a California Court to stop using, disclosing, relying on, or otherwise make publicly available Nymox privileged information, and to return all Nymox material to the Company

IRVINE, Calif., Nov. 03, 2023 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (“Nymox” or the "Company") [OTC Markets---NYMXF] announced today that a United States court in Orange County, California has ruled against the group of ex-employees and agents Lanham, Riley, and Cutler, as well as their Nevada company. The Superior Court of the State of California, Orange County ruled in favor of Nymox’s application for a temporary restraining order, and ordered Randall Lanham, Richard Cutler, Christopher Riley, and their Nevada company (“defendants”) from using, disclosing, relying on, or otherwise making publicly available any Nymox attorney-client privileged information, and to turn over or make available to Nymox any and all Nymox Information and Nymox Property in their possession, custody, or control.

This is a positive step in Nymox’s efforts to protect its shareholders from the defendants’ numerous attempts, with funding by the AscellaHealth company (“Ascella”), to essentially steal all of the Company’s assets. The Court Order also will ensure the return to the Company of its corporate documents that the Company’s former General Counsel, Mr. Lanham has refused to return, despite being ethically bound to do so. This also protects the Company’s shareholders by preventing the further disclosure and release of highly sensitive attorney-client privileged information that Mr. Lanham has publicly disclosed and used to benefit himself, and harm the Company and its shareholders.

Given this Order, we urge all shareholders to contact Nymox if they receive or have received communications from any of the above-mentioned individuals, including CRNSV, that they believe may contain Nymox attorney-client privileged information.

Nymox is pleased to have the support of the vast majority of its shareholders, and to know that, despite many months and hundreds of thousands of dollars, the Riley-Lanham group and its co-conspirators have only managed to garner the support of a small group of shareholders.

More good milestones to follow for your Company.

Paul Averback MD, CEO of Nymox said, "We are extremely pleased that the California Court has agreed with us, and enjoined the defendants from using, disclosing, relying on, or otherwise making publicly available highly sensitive privileged information. We again thank our long-term supporters and all team members and expert collaborators from many disciplines for their solid contributions and steady efforts involved in the ongoing process. We will continue to provide updates and communications to our valued supporters whenever appropriate."